Direct-to-Consumer Marketing of High-Technology Screening Tests
- 14 February 2002
- journal article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 346 (7), 529-531
- https://doi.org/10.1056/nejm200202143460715
Abstract
The authors sharply criticize the now-common practice of marketing high-technology medical screening tests directly to the consumer. As a prominent example, they select electron-beam computed tomography to screen for lung cancer. The authors voice concern about the validity of such screening, the financial consequences, and potential ethical problems.Keywords
This publication has 12 references indexed in Scilit:
- Direct-to-Consumer Advertising — Strengthening Our Health Care SystemThe New England Journal of Medicine, 2002
- Annals of Internal MedicineJAMA, 2001
- Screening for Lung CancerThe New England Journal of Medicine, 2000
- Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-upJNCI Journal of the National Cancer Institute, 2000
- American College of Cardiology/American Heart Association Expert Consensus Document on Electron-Beam Computed Tomography for the Diagnosis and Prognosis of Coronary Artery DiseaseCirculation, 2000
- Correlation of Tumor Size and Survival in Patients With Stage IA Non-small Cell Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2000
- Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populationsThe American Journal of Cardiology, 2000
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- Coronary Calcium Does Not Accurately Predict Near-Term Future Coronary Events in High-Risk AdultsCirculation, 1999
- What Is Left of Professionalism after Managed Care?Hastings Center Report, 1999